基于PROISCD-GM(V1.0)慢性胃炎患者最小临床重要性差值的制定OACSTPCD
Establishing minimum clinically important difference in patients with chronic gastritis based on the PROISCD-GM(V1.0)
目的 制定慢性胃炎PROISCD-GM(V1.0)的最小临床重要性差值(MCID).方法 采用PROISCD-GM(V1.0)及生命质量测定量表(SF-36)在治疗前后对患者进行2次横断面调查,然后采用锚法和分布法计算检验量表各领域及总量表的MCID,结合两种方法加权得到最终的MCID.结果 慢性胃炎PROISCD-GM(V1.0)治疗前后得分差异有统计学意义(P＜0.001),量表的身体健康、心理健康、社会健康、精神/信仰健康维度和总量表的MCID分别为9.52、9.01、6.25、8.33、8.21分.结论 当量表得分超过MCID时,可认为干预措施具有实际临床意义,制定的MCID可为慢性胃炎的相关临床决策和疗效评价提供依据.
Objective To establish the Minimum Clinically Important Difference(MCID)for PROISCD-GM(V1.0)in patients with chronic gastritis.Methods Two cross-sectional surveys were conducted using PROISCD-GM(V1.0)and SF-36 before and after treatment.The MCID for each domain and the total score of the questionnaire were calculated using the anchor and distribution methods.The final MCID was obtained by combining the results from both methods.Results The difference in scores before and after treatment with PROISCD-GM(V1.0)for chronic gastritis was statistically significant(P＜0.001).The MCID for the dimensions of physical health,mental health,social health,spiritual/religious health,and the total score were 9.52,9.01,6.25,8.33,and 8.21 points,respectively.Conclusion When the score exceeds the MCID,it can be considered that the intervention measures have practical clinical signifi-cance.The established MCID can provide a basis for relevant clinical decisions and efficacy evaluation in the management of chronic gastritis.
陈媛玲;李瑞雨;宋静;赵虎;缪秋菊;罗娜;陈莹
曲靖医学高等专科学校公共卫生与健康管理学院(云南曲靖 655000)昆明医科大学公共卫生学院(云南昆明 650500)云南省中西医结合医院感染管理科(云南昆明 650224)曲靖市第一人医院胃肠外科(云南曲靖 655000)
预防医学
慢性胃炎最小临床重要性差值患者报告结局疗效评价
chronic gastritisminimal clinically important differencepatient-reported outcomesefficacy eval-uation
《广东医学》 2024 (002)
慢性消化系统疾病患者报告结局量表“模块式”研制及其在移动医疗健康APP中的应用
171-176 / 6
国家自然科学基金资助项目(72164024),云南省教育厅公共卫生与疾病防控重点实验室重点课题(2023ZD10),云南省教育厅科学研究基金项目(2022J1535),云南省中青年学术和技术带头人后备人才项目(202305AC160046)
评论